Changing Treatment Landscapes of Haematological Malignancy, The Targeted and Immunotherapy Focusing on lymphomas and Plasma Cell Myelomas: Real Life Experiences in 2019, What We Do, When and The Future
Amin Islam Backgrounds: Targeted and Immunotherapy have changed treatment practices for many haematological malignancies. Even in the current era of targeted, immunotherapies and check point inhibitors, chemotherapy remains the backbone of treatment for many haematological malignancies. Application of novel immunotherapies … Continue reading →